← REGULATORY CHANGES
FEDERAL REGISTER · RULEMay 15, 2024IN FORCE

Index of Legally Marketed Unapproved New Animal Drugs for Minor Species

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVEMay 15, 2024
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGDrugVeterinary
Document type
Rule
Agency
Health and Human Services Department
Published
May 15, 2024
Effective
May 15, 2024
Document number
2024-10602
CFR references
21 CFR 516
Docket
FDA-2006-N-0239
ABSTRACT

The Food and Drug Administration (FDA, the Agency, or we) is amending the animal drug regulations for labeling of new animal drugs included on FDA's Index of Legally Marketed Unapproved New Animal Drugs for Minor Species (indexed products) to reflect the 2018 statutory changes to the Federal Food, Drug, and Cosmetic Act (FD&C Act). This amendment is intended to ensure accuracy and clarity in the Agency's regulations. This amendment is nonsubstantive.

Abstract as published in the Federal Register.